EVNIN LUKE sold 6.0% of their position (100.58K shares) of WEREWOLF THERAPEUTICS, INC. on the open market
Open‑market sale worth $64.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 5/7/2026ACC: 0001134657-26-000009
Director10% Owner
Since Apr 2021
-100.58K
Net shares
Net seller
$64.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
100.58K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−6.86K
Price / share
$0.69
Trade value
$4.73K
% of position
0.4%
5/5/2026
1.68M→1.67M
Common Stock
Indirect
Shares
−14.63K
Price / share
$0.66
Trade value
$9.66K
% of position
0.9%
5/6/2026
1.67M→1.66M
Common Stock
Indirect
Shares
−79.09K
Price / share
$0.63
Trade value
$49.82K
% of position
4.8%
5/7/2026
1.66M→1.58M
Total
Net shares
−100.58K
Net value
-$64.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/5/2026 | S · Sale | −6.86K | $0.69 | $4.73K | 0.4% | 1.68M | 1.67M |
| Common Stock Indirect | 5/6/2026 | S · Sale | −14.63K | $0.66 | $9.66K | 0.9% | 1.67M | 1.66M |
| Common Stock Indirect | 5/7/2026 | S · Sale | −79.09K | $0.63 | $49.82K | 4.8% | 1.66M | 1.58M |
| Total | −100.58K | -$64.22K | ||||||
Derivative Transactions0
No derivative transactions reported